Sunnyvale, CA, United States of America

Glen R Elliott


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1990-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Glen R. Elliott: Innovator in Appetite Suppression

Introduction

Glen R. Elliott is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of appetite suppression through his innovative methods and compounds. With a total of 2 patents, Elliott's work has the potential to impact various aspects of health and wellness.

Latest Patents

Elliott's latest patents focus on methods of suppressing appetite by the administration of specific compounds. The first patent describes compounds of formula I that are useful for suppressing appetite and altering macronutrient preferences. The compounds are designed to meet a defined quantitative structure-activity relationship (QSAR) related to the partition coefficient, net charge on the ring nitrogen, and radical superdelocalizability at the position-8 ring carbon. The second patent expands on this concept, detailing compounds that not only suppress appetite but also alter macronutrient preferences, suppress obsessive-compulsive behavior, and inhibit cravings and substance abuse.

Career Highlights

Elliott has established himself as a key figure in the field of appetite suppression. His work at Neurex Corporation has allowed him to explore innovative solutions to complex health issues. His patents reflect a deep understanding of biochemistry and pharmacology, showcasing his commitment to advancing medical science.

Collaborations

Elliott has collaborated with notable professionals in his field, including Jack D. Barchas and Peter I. Adriaenssens. These collaborations have likely contributed to the depth and breadth of his research and innovations.

Conclusion

Glen R. Elliott's contributions to appetite suppression through his patents demonstrate his innovative spirit and dedication to improving health outcomes. His work at Neurex Corporation and collaborations with esteemed colleagues further highlight his impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…